Home
>
National Drug Code (NDC)
>
Minipress
Minipress - 0069-4370-71 - (PRAZOSIN HYDROCHLORIDE)
Drug Information of Minipress
| Product NDC: | 0069-4370 |
| Proprietary Name: | Minipress |
| Non Proprietary Name: | PRAZOSIN HYDROCHLORIDE |
| Active Ingredient(s): | 2 mg/1 & nbsp; PRAZOSIN HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Minipress
| Product NDC: | 0069-4370 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017442 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19940510 |
Package Information of Minipress
| Package NDC: | 0069-4370-71 |
| Package Description: | 250 CAPSULE in 1 BOTTLE (0069-4370-71) |
NDC Information of Minipress
| NDC Code | 0069-4370-71 |
| Proprietary Name | Minipress |
| Package Description | 250 CAPSULE in 1 BOTTLE (0069-4370-71) |
| Product NDC | 0069-4370 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PRAZOSIN HYDROCHLORIDE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19940510 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | PRAZOSIN HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
